ATE530566T1 - Hunde impfstoff zum schutz gegen ehrlichiosis - Google Patents

Hunde impfstoff zum schutz gegen ehrlichiosis

Info

Publication number
ATE530566T1
ATE530566T1 AT05735365T AT05735365T ATE530566T1 AT E530566 T1 ATE530566 T1 AT E530566T1 AT 05735365 T AT05735365 T AT 05735365T AT 05735365 T AT05735365 T AT 05735365T AT E530566 T1 ATE530566 T1 AT E530566T1
Authority
AT
Austria
Prior art keywords
protect against
ehrlichiosis
dog vaccine
vaccine
dog
Prior art date
Application number
AT05735365T
Other languages
English (en)
Inventor
Liangbiao Hu
Thomas Hess
Yu-Wei Chiang
Hsien-Jue Chu
Original Assignee
Wyeth Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Llc filed Critical Wyeth Llc
Application granted granted Critical
Publication of ATE530566T1 publication Critical patent/ATE530566T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/29—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Richettsiales (O)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0233—Rickettsiales, e.g. Anaplasma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AT05735365T 2004-03-11 2005-03-10 Hunde impfstoff zum schutz gegen ehrlichiosis ATE530566T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55235004P 2004-03-11 2004-03-11
PCT/US2005/007875 WO2005087803A1 (en) 2004-03-11 2005-03-10 A canine vaccine for protection against ehrlichiosis

Publications (1)

Publication Number Publication Date
ATE530566T1 true ATE530566T1 (de) 2011-11-15

Family

ID=34965712

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05735365T ATE530566T1 (de) 2004-03-11 2005-03-10 Hunde impfstoff zum schutz gegen ehrlichiosis

Country Status (22)

Country Link
US (2) US20050202046A1 (de)
EP (2) EP2338903A1 (de)
JP (1) JP2008500962A (de)
KR (1) KR20060129475A (de)
CN (1) CN1930185A (de)
AR (1) AR048030A1 (de)
AT (1) ATE530566T1 (de)
AU (1) AU2005222396A1 (de)
BR (1) BRPI0508655A (de)
CA (1) CA2558047A1 (de)
CO (1) CO5721012A2 (de)
CY (1) CY1112120T1 (de)
DK (1) DK1723170T3 (de)
ES (1) ES2374278T3 (de)
IL (1) IL177860A0 (de)
ME (1) ME01252B (de)
PL (1) PL1723170T3 (de)
PT (1) PT1723170E (de)
RS (1) RS52188B (de)
SI (1) SI1723170T1 (de)
WO (1) WO2005087803A1 (de)
ZA (1) ZA200607547B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020115840A1 (en) * 1998-11-30 2002-08-22 Walker David H. Homologous 28-kilodaltion immunodominant protein genes of Ehrlichia canis and uses thereof
MX2009004866A (es) * 2006-11-03 2009-05-19 Schering Plough Ltd Vacuna para enfermedad de lyme canina.
US8084039B2 (en) 2007-04-06 2011-12-27 Inviragen, Inc. Methods and compositions for live attenuated viruses
EP2187958B1 (de) * 2007-09-11 2016-12-21 Yissum Research Development Company of the Hebrew University of Jerusalem Abgeschwächter ehrlichiose-impfstoff
US9051557B2 (en) * 2007-09-12 2015-06-09 Intervet International B.V. Method for continuously culturing Ehrlichia canis
BRPI0817090A2 (pt) 2007-09-12 2014-11-25 Intervet Int Bv Método de cultura e uma espécie bacteriana da família anaplasmataceae, e, composição.
EP2045816A1 (de) * 2007-10-01 2009-04-08 Paul Scherrer Institut Schnelles Auslesungsverfahren und Schaltkondensator-Arrayschaltung zur Wellenform-Digitalisierung
US8790660B2 (en) * 2010-07-02 2014-07-29 Intervet Inc. Vaccine against Ehrlichia canis
EP2433646A1 (de) * 2010-09-22 2012-03-28 Intervet International BV Impfstoff gegen Ehrlichia canis und zugehörige Verfahren
BR112015008036B1 (pt) 2012-10-11 2022-09-13 Zoetis Services Llc População de peptídeos isolados, método para detectar em uma amostra um anticorpo, método para diagnosticar erliquiose monocítica e/ou granulocítica, método para detectar a presença de anticorpos e kit
US9580758B2 (en) 2013-11-12 2017-02-28 Luc Montagnier System and method for the detection and treatment of infection by a microbial agent associated with HIV infection
US9442112B2 (en) * 2014-04-04 2016-09-13 Abaxis, Inc. Compositions and methods for identifying Ehrlichia species
WO2019027670A1 (en) * 2017-07-31 2019-02-07 Kansas State University Research Foundation VACCINES AGAINST DISEASES TRANSMITTED BY TICK
WO2020023950A1 (en) 2018-07-27 2020-01-30 Research Development Foundation Chimeric immunogenic polypeptides
AU2020314625A1 (en) * 2019-07-12 2022-02-03 Research Development Foundation Ehrlichia vaccines and immunogenic compositions

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192679A (en) * 1990-05-03 1993-03-09 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Growing ehrlichia species in a continuous cell line
ATE196425T1 (de) * 1990-07-06 2000-10-15 American Home Prod Impfstoff gegen die lyme-krankheit
US5972350A (en) * 1996-05-06 1999-10-26 Bayer Corporation Feline vaccines containing Chlamydia psittaci and method for making the same
AU7208698A (en) * 1997-03-24 1998-10-20 Merial Canine ehrlichiosis immunogenic and diagnostic compositions and methods
US6043085A (en) 1998-08-27 2000-03-28 Research Development Foundation Ehrlichia canis 120-kDa immunodominant antigenic protein and gene
US6458942B1 (en) * 1998-11-30 2002-10-01 Research Development Foundation 28-kDa immunoreactive protein gene of Ehrlichia canis and uses thereof
US6432649B1 (en) 2000-08-25 2002-08-13 The Ohio State University Research Foundation Methods for detecting Ehrlichia canis and Ehrlichia chaffeensis in vertebrate and invertebrate hosts
SV2003000753A (es) * 2000-12-05 2003-06-16 Brigham & Womens Hospital Uso de polisacaridos zwitterionicos para la especifica modulacion del progreso inmunologico
US20030129161A1 (en) * 2001-09-17 2003-07-10 Hsien-Jue Chu Interleukin-12 as a veterinary vaccine adjuvant

Also Published As

Publication number Publication date
EP1723170B1 (de) 2011-10-26
CY1112120T1 (el) 2015-11-04
SI1723170T1 (sl) 2012-01-31
CO5721012A2 (es) 2007-01-31
ME01252B (me) 2013-06-20
ZA200607547B (en) 2008-06-25
IL177860A0 (en) 2006-12-31
PT1723170E (pt) 2012-01-10
JP2008500962A (ja) 2008-01-17
ES2374278T3 (es) 2012-02-15
AR048030A1 (es) 2006-03-22
DK1723170T3 (da) 2011-12-05
EP1723170A1 (de) 2006-11-22
AU2005222396A1 (en) 2005-09-22
US20060188524A1 (en) 2006-08-24
US20050202046A1 (en) 2005-09-15
KR20060129475A (ko) 2006-12-15
PL1723170T3 (pl) 2012-03-30
CA2558047A1 (en) 2005-09-22
EP2338903A1 (de) 2011-06-29
BRPI0508655A (pt) 2007-08-14
US7635481B2 (en) 2009-12-22
RS52188B (en) 2012-10-31
WO2005087803A1 (en) 2005-09-22
CN1930185A (zh) 2007-03-14

Similar Documents

Publication Publication Date Title
ATE530566T1 (de) Hunde impfstoff zum schutz gegen ehrlichiosis
DK1959991T3 (da) Terapeutisk vaccine
ATE450271T1 (de) Impfstoff
DK2066176T3 (da) Forbedringer vedrørende plantebeskyttelse
BRPI0810929A2 (pt) "método para proteger"
DE602007002746D1 (de) Steinzerkleinerungsvorrichtung
DK1968631T3 (da) Vaccine
DK2238132T3 (da) Insekticidforbindelser
ATE544742T1 (de) Insektizide arylpyrrolidine
DK2114993T3 (da) Vaccine
DE502008003324D1 (de) Heteroaryl-substituierte piperidine
ATE432082T1 (de) Impfstoff gegen periodontale krankheit
FI20070415A0 (fi) Suojamaadoitus
DK2035369T3 (da) Terapeutiske
DK2144905T3 (da) Terapeutiske midler
DK2158199T3 (da) Piperidinforbindelser og anvendelser deraf
DK2131818T3 (da) Ny doseringsform
ATE532773T1 (de) Insektizide pyrimidinyl-aryl-hydrazone
FR2913694B1 (fr) Elements regulateurs d'expression
NO346433B1 (no) Nytt fiskepatogen
BRPI0920119A2 (pt) mistura fungicida contendo fenpropidina e penconazol
FI20075024L (fi) Antiballistinen suojarakenne
ATA9422004A (de) Verbissschutz
ATE445317T1 (de) Rückevorrichtung zum bewegen von baumstämmen
ITMI20040565A1 (it) Dispositivo per proteggere piante

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1723170

Country of ref document: EP